Advertisement
UK markets close in 3 hours 15 minutes
  • FTSE 100

    8,151.61
    +4.75 (+0.06%)
     
  • FTSE 250

    20,144.72
    +24.36 (+0.12%)
     
  • AIM

    776.06
    +0.02 (+0.00%)
     
  • GBP/EUR

    1.1822
    -0.0023 (-0.19%)
     
  • GBP/USD

    1.2665
    -0.0020 (-0.16%)
     
  • Bitcoin GBP

    51,865.89
    -602.33 (-1.15%)
     
  • CMC Crypto 200

    1,369.93
    -18.23 (-1.31%)
     
  • S&P 500

    5,431.60
    -2.14 (-0.04%)
     
  • DOW

    38,589.16
    -57.94 (-0.15%)
     
  • CRUDE OIL

    78.71
    +0.26 (+0.33%)
     
  • GOLD FUTURES

    2,333.40
    -15.70 (-0.67%)
     
  • NIKKEI 225

    38,102.44
    -712.12 (-1.83%)
     
  • HANG SENG

    17,936.12
    -5.66 (-0.03%)
     
  • DAX

    18,053.61
    +51.59 (+0.29%)
     
  • CAC 40

    7,539.60
    +36.33 (+0.48%)
     

GameStop falls while Dave & Buster's and Blue Apron rise

GameStop falls while Dave & Buster's and Blue Apron rise

NEW YORK (AP) -- Stocks that moved substantially or traded heavily on Wednesday:

GameStop Corp., down 47 cents to $9.63

The video game retailer's first-quarter profit and revenue fell short of analysts' expectations and it gave investors a weak forecast.

Dave & Buster's Entertainment Inc., up $2.47 to $52.95

The restaurant and arcade chain's fourth-quarter profit and a key sales measure blew past Wall Street expectations.

Advanced Micro Devices Inc., up $2.27 to $29.02

The chipmaker and its rivals gained on media reports that orders for smartphone chips are higher so far this quarter.

Intel Corp., up $1.12 to $55.48

ADVERTISEMENT

The chipmaker named George Davis its new chief financial officer, after hiring him away from rival Qualcomm.

Blue Apron Holdings Inc., up 7 cents to $1.04

The meal-kit seller's CEO is resigning and will be replaced by a former Etsy Inc. executive.

Nektar Therapeutics Inc., up $1.59 to $35.29

The biotechnology company presented a series of positive early studies for potential cancer treatments.

Acuity Brands Inc., up $10.90 to $134.79

The lighting maker beat Wall Street's profit forecasts for the fiscal second quarter.

USANA Health Sciences Inc., down $2.90 to $81.25

The nutritional supplements company expects a drop in sales during the first quarter, citing a lack of promotional activity.